Uncategorized

A 5:2 Intermittent Fasting Meal Replacement Diet Beats Metformin and Empagliflozin in T2D

A randomized, open-label, active parallel-controlled clinical trial showed that 2 nonconsecutive fasting days (with a daily energy intake of 500 kcal for women and 600 kcal for men) and 5 days of habitual intake per week and meal replacement diet (5:2 MR) achieved better glycemic control compared with metformin and empagliflozin in Chinese adults with early type 2 diabetes (T2D). Between November 2020, and December 2022, 405 T2D patients diagnosed within 1 year (men 65.4%; mean age, 45.5 years; mean body mass index, 29.5; and mean HbA1c level, 7.9%) were randomly allocated in a 1:1:1 ratio to receive either metformin, empagliflozin, or 5:2 MR treatment for 16 weeks, with an 8-week follow-up. There were 332 completed the 16-week treatment. From baseline to week 16, participants in the 5:2 MR group showed the greatest reduction in HbA1c (least-squares mean [LSM], −1.9%), significantly greater than patients receiving metformin (LSM, −1.6%; adjusted LSM difference, −0.3%) and empagliflozin (LSM, −1.5%; adjusted LSM difference, −0.4%). At week 16, the mean weight loss in the 5:2 MR group (LSM, −9.7 kg) was greater than that in the metformin group (LSM, −5.5 kg) and empagliflozin group (LSM, −5.8 kg). The 5:2 MR also reduced blood pressure and triglycerides and increased HDL-C levels, consistent with previous studies indicating improved metabolic parameters with intermittent fasting and MR, indicating potential cardiovascular benefits. The findings suggest that the 5:2 MR approach may serve as an effective initial lifestyle intervention instead of antidiabetic drugs for early-stage T2D patients. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

10 hours ago

Faster Walking Pace May Reduce Risk of Cardiac Arrhythmias

A prospective UK cohort study found that both self-reported average or brisk walking pace and…

14 hours ago

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

3 weeks ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

4 weeks ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

1 month ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

1 month ago

This website uses cookies.